Literature DB >> 30424825

How tuberculosis programs can navigate the world of social health insurance.

W A Wells1, G Stallworthy2, Z Balsara3.   

Abstract

Many countries with a high tuberculosis (TB) burden are adopting social health insurance (SHI) schemes. However, the national TB programs (NTPs) of these countries are only just starting to grapple with the effects of SHI on their operations. Here, we review the rationale for analyzing TB programs in light of the changes brought by SHI. We consider the influence of certain purchasing decisions on TB care and prevention, and the opportunities that SHI may present for NTPs to broaden private sector engagement, extract TB data across the health sector, and facilitate quality improvement efforts. We also explore which functions are likely to be performed by SHI systems, which require special attention with the advent of SHI, and the metrics that indicate how much of TB care seeking and treatment can be reached and influenced by SHI. SHI presents certain risks for TB programs, but also opportunities to adapt to a more modern health system and to bring quality TB care and treatment to more people.

Entities:  

Year:  2018        PMID: 30424825     DOI: 10.5588/ijtld.18.0289

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Avoiding false economies: paying for community tuberculosis outcomes.

Authors:  W A Wells
Journal:  Public Health Action       Date:  2019-06-21

2.  Predictors of Community-Based Health Insurance in Ethiopia via Multilevel Mixed-Effects Modelling: Evidence from the 2019 Ethiopia Mini Demography and Health Survey.

Authors:  Wondesen Teshome Bekele
Journal:  Clinicoecon Outcomes Res       Date:  2022-08-15

3.  Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.

Authors:  C Timire; C Sandy; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2019-11-01       Impact factor: 2.373

4.  Meet the patients where they are: A greater ambition for private provider engagement for TB.

Authors:  William A Wells; Guy Stallworthy
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.